Résumé :
|
[BDSP. Notice produite par INIST-CNRS l9rB9R0x. Diffusion soumise à autorisation]. On the basis of clinical and pathologic criteria, endometrial carcinoma has been distinguished as Types I (mainly endometrioid) and II (nonendometrioid). Limited data suggest that these subtypes have different risk factor profiles. The authors prospectively evaluated risk factors for Types I (n=1,312) and II (n=138) incident endometrial carcinoma among 114,409 women in the National Institutes of Health (NIH) - AARP Diet and Health Study (1995-2006). For individual risk factors, relative risks were estimated with Cox regression by subtype, and Pheterogeneity was assessed in case-case comparisons with Type I as the referent. Stronger relations for Type I versus Type II tumors were seen for menopausal hormone therapy use (relative risk (RR) of 1.18 vs.0.84 ; Pheterogeneity=0.01) and body mass index of>=30 vs.
|